Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy.

Autor: Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona. chiara.tarantelli@ior.usi.ch., Wald D; Case Western Reserve University, Cleveland, OH., Munz N; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Bruscaggin A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cannas E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne., Manjappa S; Fred Hutchinson Cancer Center, Seattle, Washington., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Scalise L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cacciapuoti MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona., Stathis A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biomedical Sciences, USI, Lugano., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Van Berkel PH; ADC Therapeutics (UK) Ltd., London., Rossi D; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona., Caimi PF; Cleveland Clinic/Case Comprehensive Cancer Center, Cleveland, OH., Zammarchi F; ADC Therapeutics (UK) Ltd., London., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona. francesco.bertoni@ior.usi.ch.

Publikováno v: Haematologica [Haematologica] 2024 Oct 01; Vol. 109 (10), pp. 3314-3326. Date of Electronic Publication: 2024 Oct 01.

An Appraisal of Fluoride Distribution and Ionic Balance in Ground Water of Mundaragi Taluk, Gadag District, Karnataka, India: A Case Study

Autor: Suresh B, Manjappa S, K. Lokesh, Aswini Arali

Publikováno v: Journal of Geoscience and Environment Protection. :1-13

A total, 25 different ground-water samples collected in Mundaragi taluk in of Gadag district, Karnataka, India to appraise the distribution of Fluoride. pH of collected groundwater is shown alkaline in nature and ranged between 7.18 and 9.32 with a m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::143b05739c1cf21630f33bd862ba4317
https://doi.org/10.4236/gep.2021.910001

Status of Groundwater Quality of Kudligi Taluk Area in Bellary district, Karnataka, India.

Autor: Kottureshwara, N. M.¹, Manjappa, S.² drsmubdtce@gmail.com, Suresh, T.³, Jayashree, M.¹

Publikováno v: International Journal of Pharmacy & Life Sciences. Apr2014, Vol. 5 Issue 4, p3467-3473. 7p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemical screening identifies novel small molecule activators of natural killer cell cytotoxicity against cancer cells.

Autor: Lee G; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Karunanithi S; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Posner B; High-Throughput Screening Core, Department of Biochemistry, UT Southwestern Medical Center, Dallas, TX, USA., Niederstrasser H; High-Throughput Screening Core, Department of Biochemistry, UT Southwestern Medical Center, Dallas, TX, USA., Cheng H; High-Throughput Screening Core, Department of Biochemistry, UT Southwestern Medical Center, Dallas, TX, USA., Federov Y; Small Molecule and Drug Discovery Facility, Case Western Reserve University, Cleveland, OH, USA., Manjappa S; Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Musaitif K; Idaho College of Osteopathic Medicine, Meridian, ID, USA., Wang H; Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Jackson Z; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Wald D; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA. dnw@case.edu.; Department of Pathology, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA. dnw@case.edu.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Jul; Vol. 71 (7), pp. 1671-1680. Date of Electronic Publication: 2021 Nov 23.